Skip to main content
RYM
NASDAQ Industrial Applications And Services

RYTHM Q3 Revenue $23.9M, $48.2M Cash — But Withholds Q4 Outlook on Federal THC Ban

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Engineering & Construction Stocks · Industrial
Sentiment info
Negative
Importance info
8
Price
$16.5
Mkt Cap
$35.956M
52W Low
$14
52W High
$50.38
52W Position info
18% above low
Off High info
67% below high
Rel. Volume info
2.3× avg
Market data snapshot near publication time

RYM sits 18% above its 52-week low of $14 on elevated volume (2.3× avg).

Summary

RYTHM reported Q3 revenue of $23.9 million and $48.2 million of cash, but refused to guide the fourth quarter because federal rules effective December 11, 2026 would ban its current hemp-derived THC products.


Key Events · Earnings and Guidance · RYM

  • Q3 Revenue $23.9M, Up 4%

    Revenue from continuing operations rose to $23.9 million from $23.0 million in the prior quarter, with operating income from continuing operations of $1.0 million and a net loss of $0.5 million.

  • Cash Builds to $48.2M

    Cash increased to $48.2 million, driven by $6.3 million of cash flow from operations; adjusted EBITDA was $5.9 million versus $6.4 million in the prior quarter.

  • No Q4 Guidance on THC Deadline

    Federal changes effective December 11, 2026 would prohibit selling current hemp-derived THC products in their existing form, and Illinois restrictions begin November 12, 2026, so the company is not providing a fourth-quarter 2026 outlook.

  • Hemp Products Drive Growth

    Hemp-derived product revenue rose 15% sequentially to $6.4 million, and THC beverage depletions grew about 15% sequentially and about 185% year-over-year to an annualized run rate of roughly 320,000 cases across about 8,000 retail doors in 18 states.


Analysis · RYM · Industrial Applications And Services

The quarter itself was solid: revenue rose 4% sequentially to $23.9 million, operating income from continuing operations turned to $1.0 million, and cash built to $48.2 million on $6.3 million of operating cash flow. What makes this more than a routine print is the guidance blackout. Federal changes taking effect December 11, 2026 would prohibit selling the company's current hemp-derived THC products in their existing form, and Illinois restrictions bite earlier, on November 12, 2026 — so management declined to give a fourth-quarter outlook at all. Hemp-derived products were $6.4 million of the quarter's revenue and the beverage business is the growth story, which puts a meaningful slice of the top line on a regulatory clock. Against that, the balance sheet carries $72.0 million of current related-party debt and $8.6 million of current long-term debt, so the $48.2 million cash pile is the buffer that determines how long the company can wait for a legislative fix.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, RYM was trading at $16.50 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $36M. The 52-week trading range was $14.00 to $50.38. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

RYM - Latest Insights

RYM
Nov 04, 2026, 7:07 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $16.50
Real-time Price: $10.30 info
Change: -$6.20 (-38%) info
Market Cap: $21.921M info
RYM
Oct 16, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $19.32
Real-time Price: $10.30 info
Change: -$9.02 (-47%) info
Market Cap: $21.921M info
RYM
Sep 03, 2026, 5:00 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $25.04
Real-time Price: $10.30 info
Change: -$14.74 (-59%) info
Market Cap: $21.921M info
RYM
Aug 11, 2026, 8:00 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $20.95
Real-time Price: $10.30 info
Change: -$10.65 (-51%) info
Market Cap: $21.921M info
RYM
Aug 11, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $21.00
Real-time Price: $10.30 info
Change: -$10.70 (-51%) info
Market Cap: $21.921M info